| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $833.9M | +0.9% |
| Cost of Revenue | $394.4M | -5.7% |
| Gross Profit | $439.5M | +7.7% |
| R&D Expense | $179.9M | -5.6% |
| SG&A Expense | $68.7M | +25.1% |
| Operating Income | $16.9M | +169.5% |
| Pre-tax Income | -$46.1M | +16.8% |
| Income Tax | $8.2M | -24.6% |
| Net Income | -$54.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.8M | +229.6% |
| Accounts Receivable | $254.7M | -5.1% |
| Inventory | $79.2M | +2.1% |
| Current Assets | $463.7M | +10.7% |
| Total Assets | $1.16B | +1.6% |
| Current Liabilities | $328.9M | -3.6% |
| Long-term Debt | $348.3M | +47.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.2M | +194.0% |
| Capital Expenditures | $22.4M | +138.8% |
| Investing Cash Flow | -$22.9M | -141.2% |
| Financing Cash Flow | $37.7M | +178.8% |
| Free Cash Flow | $27.8M | +261.2% |
| +18.1% |
| EPS (Basic) | -$0.31 | +20.5% |
| EPS (Diluted) | -$0.31 | +20.5% |
| Total Liabilities |
| $757.9M |
| +9.6% |
| Stockholders' Equity | $404.6M | -10.6% |